Results 191 to 200 of about 15,116 (246)
Developmental Medicine &Child Neurology, EarlyView.Abstract Aim To identify the outcomes reported in published studies of intervention approaches used with non‐degenerative childhood hyperkinetic movement disorders, including dystonia, dyskinesia, hypertonia, athetosis, chorea, cerebral palsy, involuntary movement, and kernicterus, and map them to the International Classification of Functioning ...
Hortensia Gimeno +10 more
wiley +1 more source
European Journal of Dental Education, EarlyView.ABSTRACT Background Artificial intelligence (AI) is already a powerful tool that is rapidly growing within the dental sector. Reports of structure and characteristics of AI responses to patient scenarios are limited. Purpose To analyse characteristics and structure of AI responses to prompts for treatment planning alternatives and patient alternatives ...
David C Johnsen +4 more
wiley +1 more source
Individual differences in set‐shifting and levodopa responsiveness in Parkinson's disease
Journal of Neuropsychology, EarlyView.Abstract Perseveration (PE) and learned irrelevance (LI) are two distinct processes that shape attentional set‐shifting in Parkinson's disease (PD). Whether LI and PE are dopamine‐dependent remains unclear. We investigated whether PE and LI may be dissociated in early PD and whether these switch conditions are associated with an individual motor ...
Aleksandra Fijałkiewicz +5 more
wiley +1 more source
Journal of Sleep Research, Volume 34, Issue 2, April 2025.Summary Parasomnias and sleep‐related movement disorders (SRMD) are major causes of sleep disorders and may be drug induced. The objective of this study was to conduct a systematic review of the literature to examine the association between drug use and the occurrence of parasomnias and SRMD.
Sylvain Dumont +5 more
wiley +1 more source
Journal of Sleep Research, EarlyView.ABSTRACT Although many studies have reported the presence of daytime sleepiness in Parkinson's disease (PD), either a weak or no association has been found between self‐reported and current objective measures of daytime sleepiness in this population. Changes in resting state quantitative electroencephalography (qEEG) have been associated with increased
Thaïna Rosinvil +5 more
wiley +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Clinical Pharmacology & Therapeutics, 1971
Based on the chemical constitution and metabolism of levodopa as well as on the effects of long‐term therapy in patients with parkinsonism, a hypothesis of pharmacologic activity which clearly differentiates it from conventional antiparkinsonian drugs is proposed.
G C, Cotzias +3 more
openaire +2 more sources
Based on the chemical constitution and metabolism of levodopa as well as on the effects of long‐term therapy in patients with parkinsonism, a hypothesis of pharmacologic activity which clearly differentiates it from conventional antiparkinsonian drugs is proposed.
G C, Cotzias +3 more
openaire +2 more sources
Journal of Neurology, 2010
This paper reviews the clinically relevant determinants of levodopa peripheral pharmacokinetics and main observed changes in the levodopa concentration-effect relationship with Parkinson's disease (PD) progression. Available clinically practical strategies to optimise levodopa pharmacokinetics and pharmacodynamics are briefly discussed.
Manuela, Contin, Paolo, Martinelli
openaire +2 more sources
This paper reviews the clinically relevant determinants of levodopa peripheral pharmacokinetics and main observed changes in the levodopa concentration-effect relationship with Parkinson's disease (PD) progression. Available clinically practical strategies to optimise levodopa pharmacokinetics and pharmacodynamics are briefly discussed.
Manuela, Contin, Paolo, Martinelli
openaire +2 more sources
JAMA: The Journal of the American Medical Association, 1972
To the Editor.— Entitled "Psychiatric Side Effects of Levodopa in Man,"1Frederick Goodwin's article inThe Journaldescribed visual hallucinations among the adverse side effects in Parkinsonian patients treated with levodopa. Prior to this, others2-6described psychosis as an occasional adverse side effect of therapy with levodopa.
openaire +2 more sources
To the Editor.— Entitled "Psychiatric Side Effects of Levodopa in Man,"1Frederick Goodwin's article inThe Journaldescribed visual hallucinations among the adverse side effects in Parkinsonian patients treated with levodopa. Prior to this, others2-6described psychosis as an occasional adverse side effect of therapy with levodopa.
openaire +2 more sources
The American Journal of Nursing, 1974
chronic care facility with no hope of improvement. Parkinsonism is a fairly common, disabling, movement disorder caused by dysfunction of the extrapyramidal system. There are 90 to 110 cases per 100,000 people and an annual incidence of 20 cases per 100,000 people in the United States(1).
openaire +2 more sources
chronic care facility with no hope of improvement. Parkinsonism is a fairly common, disabling, movement disorder caused by dysfunction of the extrapyramidal system. There are 90 to 110 cases per 100,000 people and an annual incidence of 20 cases per 100,000 people in the United States(1).
openaire +2 more sources
Neurology, 1998
Whether a drug such as levodopa, which is prescribed for long periods, may be toxic is a legitimate and even indispensable question. The problem is no different from that posed by other drugs-such as calcium antagonists, antihypertensives, or hormones-normally prescribed for chronic diseases. What, however, is meant in this context by "toxic" (from the
openaire +2 more sources
Whether a drug such as levodopa, which is prescribed for long periods, may be toxic is a legitimate and even indispensable question. The problem is no different from that posed by other drugs-such as calcium antagonists, antihypertensives, or hormones-normally prescribed for chronic diseases. What, however, is meant in this context by "toxic" (from the
openaire +2 more sources